Enhancement of antiproliferative activity of 1α,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 3-4, 1996, Pages 197-202

  Zhao, J ^a   Tan, B K ^a   Marcelis, S ^a   Verstuyf, A ^a   Bouillon, R ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEGENDO   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD 99; COLECALCIFEROL DERIVATIVE; CYTOCHROME P450; ENZYME INHIBITOR; KETOCONAZOLE; LEXACALCITOL; LIARAZOLE; RO 23 6010; UNCLASSIFIED DRUG; ZXY 835;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; TUMOR CELL;

EID: 0029980971     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00256-1     Document Type: Article

References (37)

1. Bikle D. D.: Clinical counterpoint. Vitamin D: new actions, new analogs, new therapeutic potential. Endocrine Rev. 13 (1992) 765-784.
2. Bouillon R., Okamura W. H. and Norman A. W.: Structure-function relationships in the vitamin D endocrine system. Endocrine Rev. 16 (1995) 200-257.
3. Lowe K. E., Maiyar A. C. and Norman A. W.: Vitamin D-mediated gene expression. Crit. Rev. Eukar. Gene. Exp. 2 (1992) 65-109.
4. Pike J. W.: Insights into the genomic mechanisms of 1,25-dihydroxyvitamin D3. Steroid hormone receptors. In Basic and Clinical Aspects (Edited by V. K. Moudgil). Birkhauser, Boston (1994) pp. 163-191.
5. Carlberg C., Bendik L., Wyss A., Meier E., Sturzenbacker L. J., Grippo J. F. and Hunziker W.: Two nuclear signalling pathways for vitamin D. Nature 361 (1993) 657-660.
6. Mahonen A., Pirskanen A. and Maenpaa P. H.: Homologous and heterologous regulation of 1,25-dihydroxyvitamin D-3 receptor mRNA level in human osteosarcoma cells. Biochem. Biophys. Acta 1088 (1991) 111-118.
7. 3 receptor in a culture human breast cancer cell line (MCF 7 Cells). Biochem. Biophys. Res. Commun. 93 (1980) 9-15.
8. 3 receptors in T 47D breast cancer cells. J. Steroid Biochem. Molec. Biol. 45 (1993) 257-263.
9. 3 binding activity during leukemic cell differention. Leukemia Res. 17 (1993) 97-101.
10. 3 or its derivatives. J. Biol. Chem. 269 (1994) 2971-2981.
11. Jaaskelainen T., Pirskanen A., Ryhanen S., Palvimo J. J., Deluca H. F. and Maenpaa P. H.: Functional interference between AP-1 and the vitamin D receptor on osteocalcin gene expression in human osteosarcoma cells. Eur. J. Biochem. 224 (1994) 11-20.
12. Titcomb M. W., Gottardis M. M., Pike J. W. and Allegretto E. A.: Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts. Molec. Endocr. 8 (1994) 870-877.
13. Roman S. D., Clarke C. L., Hall R. E., Alexander I. E. and Sutherland R. L.: Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 52 (1992) 2236-2242.
14. Wouters W., van Dun J., Dillen A., Coene M. C., Cools W. and De Coster R.: Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res. 52 (1992) 2841-2846.
15. Zhao J., Marcelis S., Tan B. K., Verstuyf A. and Bouillon R.: Potentialisation of vitamin D (analogs) by cytochrome P-450 enzyme inhibitors is analog- and cell-type specific. In Vitamin D, a Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Application (Edited by A. W. Norman, R. Bouillon and M. Thomasset). Walter de Gruyter, Berlin (1994) pp. 186-187.
16. Beggs W. H., Andrews F. A. and Sarosi G. A.: Action of imidazole-containing antifungal drugs. Life Sci. 28 (1981) 111-118.
17. Van Wauwe J., Van Nyen G., Coene M. C., Stoppie P., Cools W., Goossens J., Borghgraef P. and Janssen P. A. J.: Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J. Pharmac. Exp. Ther. 261 (1992) 773-779.
18. De Coster R., Van Ginckel R. F., Callens M. J. L., Goeminne N. K. G. and Janssen B. L. E.: Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors. Cancer Res. 52 (1992) 1240-1244.
19. De Coster R., Van Ginckel R., van Moorselaar R. J. A., Schalken J. A., Debruyne F. M. J., Bruynseels J. and Denis L.: Antitumoral effects of R75251 in prostatic carcinoma: experimental and clinical studies. Proc. Am. Assoc. Cancer Res. 32 (1991) 213.
20. 24 gene. Nucl. Acids Res. 22 (1994) 2410-2416.
21. 3 in cultured bovine parathyroid cells. Endocrinology 130 (1991) 276-281.
22. Cali J. J., Hsieh C. L., Francke U. and Russell D. W.: Mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 12 (1991) 7779-7783.
23. Guo Y. D., Strugnell S., Back D. W. and Jones G.: Transfected human liver cytochrome P -450 hydroxylates vitamin D analogs at different side-chain positions. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 8668-8672.
24. 450 messenger ribonucleic acid level in primary cultures of rat renal cells. Endocrinology 132 (1993) 1782-1788.
25. 3 receptor up-regulation in rat osteosarcoma cells. Arch. Biochem. Biophys. 272 (1989) 459-465.
26. Bouillon R., Allewaert K., Van Leeuwen J. P. I. M., Tan B. K., Xiang D. Z., De Clercq P., Vandewalle M., Pols H. A. P., Bos M. P., Van Baelen H. and Birkenhager J. C.: Structure function analysis of vitamin D analogs with C-ring modifications. J. Biol. Chem. 267 (1992) 3044-3051.
27. Bouillon R., Vandershueren D., Van Herk E., Nielsen H. K., Bex M., Heyns W. and Van Baelen H.: Homologous radiommunoassay of human osteocalcin. Clin. Chem. 38 (1992) 2055-2060.
28. Feldman D.: Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocrine Rev. 7 (1986) 409-420.
29. Adams J. S., Beeker T. G., Hongo T. and Clemens T. L.: Constitutive expression of a vitamin D 1-hydroxylase in a myelomonocytic cell line: a model for studying 1,25-dihydroxyvitamin D production in vitro. J. Bone Miner. Res. 5 (1990) 1265-1269.
30. 3-1(-hydroxylase) in porcine hepatic tissue: subcellular localization to both mitochondria and microsomes. Proc. Natn. Acad. Sci. U.S.A. 87 (1990) 6009-6013.
31. Christou M., Savas U., Spink D. C., Gierthy J. F. and Jefcoate C. R.: Co-expression of human CYP1A1 and an human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells. Carcinogenesis 15 (1994) 725-732.
32. Pols H. A. P., Schute H. P., Visser T. J. and Birkenhager J. C.: Effect of ketoconazole on metabolism and binding of 1,25-dihydroxyvitamin D-3 by intact rat osteogenic sarcoma cells. Biochem. Biophys. Acta 931 (1987) 115-119.
33. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmac. 42 (1991) 1569-1575.
34. 3 prolongs survival time of leukemic mice. Proc. Natn. Acad. Sci. U.S.A. 87 (1990) 3929-3932.
35. 3 is due to reduced catabolism and altered protein binding. Biochem. Pharmac. 47 (1994) 987-993.
36. 3 in rat kidney using on-line HPLC-electrospray tandem mass spectrometry. In Vitamin D, a Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Application (Edited by A. W. Norman, R. Bouillon and M. Thomasset). Walter de Gruyter, Berlin (1994) pp. 196-197.
37. Van Baelen H., Convents R. and Bouillon R.: Activity of vitamin D analogs in co-transfected cos-7 cells. In Vitamin D, a Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Application (Edited by A. W. Norman, R. Bouillon and M. Thomasset). Walter de Gruyter, Berlin (1994) pp. 77-78.